- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: FSR Peptide 200μM
Total 15229 results
-
University of Banja LukaCompletedPsoriasis Vulgaris | Diabetes Type 2Bosnia and Herzegovina
-
Novo Nordisk A/SActive, not recruitingAlzheimers DiseaseUnited States, Canada, Italy, Sweden, Denmark, Switzerland
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 2China
-
Sabine Mueller, MD, PhDBristol-Myers Squibb; Pacific Pediatric Neuro-Oncology Consortium; The V Foundation...CompletedGlioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-MutantUnited States, Switzerland
-
Samsung Medical CenterEver Neuro Pharma GmbHCompletedStrokeKorea, Republic of
-
SanofiCompleted
-
Maruho Co., Ltd.Completed
-
Novo Nordisk A/SRecruitingObesityBelgium, United Kingdom, United States, Portugal, Austria, Germany, Mexico, Sweden, Denmark, Israel
-
Novo Nordisk A/SActive, not recruitingObesity | OverweightTaiwan, China
-
National Institute of Allergy and Infectious Diseases...The University of Texas Health Science Center, HoustonCompletedHIV Infections | Non-Alcoholic Fatty Liver DiseaseUnited States, Brazil
-
Boston Children's HospitalTerminatedHeart Defects, Congenital | Cardiopulmonary BypassUnited States
-
Samsung Medical CenterCompletedCerebrolysinKorea, Republic of
-
Mayo ClinicCompletedAcute Myocardial InfarctionUnited States
-
DarierUnknown
-
University of BolognaEuropean CommissionUnknown
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, China, South Africa, Slovakia
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Thailand, Poland, Czechia, Malaysia, Serbia
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
University of PalermoRecruitingNon-celiac Gluten/Wheat SensitivityItaly
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
BioMarin PharmaceuticalApproved for marketingCLN2 DiseaseUnited Kingdom, United States, Germany, Italy
-
University of PatrasCompleted
-
University of Sao Paulo General HospitalNot yet recruiting
-
McMaster UniversityCompleted
-
Novo Nordisk A/SRecruitingObesityCanada, United Kingdom, United States, Germany, France
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedGastrointestinal Diseases | Gastrointestinal Stromal Tumor (GIST) | Gastric (Stomach) CancerUnited States
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer´s DiseaseCanada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Vanderbilt University Medical CenterNashville VA Medical CenterActive, not recruitingChronic Kidney DiseasesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Denmark, Sweden, Austria
-
United States Army Research Institute of Environmental...Not yet recruitingHealthy VolunteersUnited States
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Qilu Pharmaceutical Co., Ltd.Completed
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Serbia, Italy, China, Poland, Hungary, Saudi Arabia
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseSpain, United States, Poland, Thailand, India, France, Argentina, Brazil, Canada, Japan, Greece, Slovakia, Hungary
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Oslo University HospitalUniversity of Oslo; University Hospital, AkershusRecruiting
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, India, United States, China, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
Novo Nordisk A/SCompletedObesityUnited States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2India